Teresa A. Brentnall, MD

Tumorigenesis in the gastrointestinal tract with emphasis in 3 areas of research:

1. Molecular events and early detection of pancreatic cancer.

2. Surveillance and management of patients who inherit pancreatic cancer.

3. Molecular events, prevention, and early detection of colon cancer in patients with inflammatory bowel disease.

Chen R, Yi E, Donohoe S, Pan S, Eng J, Cooke K, Keller A, Nesvizhskii A, Li X, Crispin D, Goodlett D, Bronner MP, Aebersold R, Brentnall TA. Pancreatic Cancer Proteome: The Proteins that Underlie Invasion, Metastasis, and Immunologic Escape. Gastroenterology 2005;129: 1187-97.


Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: improvements in our understanding of genetics and screening. Int J Biochem Cell Biol. 2004; 36: 1386-92


Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB. Early diagnosis and treatment of pancreatic neoplasia in patients with a family history of pancreatic cancer. Ann Int Med. 1999; 131: 247-255.


Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Koprowicz KM, ƒnBronner MP, Brentnall TA. DNA Fingerprinting Abnormalities Can Distinguish UC Patients With Dysplasia And Cancer From Those Who Are Dysplasia/Cancer Free. Am J Path. 2003; 162: 665-72.